Loading...

Heyu Biological Technology Corporation

HYBTPNK
Healthcare
Medical - Devices
$0.35
$-0.25(-41.67%)

Heyu Biological Technology Corporation (HYBT) Stock Overview

Explore Heyu Biological Technology Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap361.4M
P/E Ratio-1565.59
EPS (TTM)N/A
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.51

HYBT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Heyu Biological Technology Corporation (HYBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1565.59 and a market capitalization of 361.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;